HealthMap

Strontium Ranelate and Vertebral Fracture Risk

• Clinical Evidence: Clinical trials and research data indicate that strontium ranelate can significantly reduce the risk of vertebral fractures in postmenopausal women with osteoporosis.
• Mechanism: It functions through a dual mode of action, which involves reducing bone resorption while simultaneously maintaining or increasing bone formation.
• Nutritional and Mineral Context:
• Bone density and fracture risk are fundamentally tied to the overall mineral and nutritional balance of the body.
• Adequate levels of calcium, magnesium, vitamin D, and trace minerals are essential prerequisites for optimal bone remodeling and structural integrity.
• Clinical Cautions:
• Prescription interventions such as strontium ranelate must be evaluated carefully due to potential cardiovascular and systemic side effects.
• A comprehensive approach should prioritize dietary optimization, targeted nutritional supplementation, and lifestyle factors to support long-term skeletal health safely.